Paeds SAQs · ophthalmology
Leukocoria and retinoblastoma: SAQ
Short-answer questions on leukocoria and retinoblastoma in children, covering the white pupillary reflex as the red-flag sign, the RB1 tumour suppressor gene on chromosome thirteen and the Knudson two-hit hypothesis, the International Intraocular Retinoblastoma Classification, the urgent referral and the red reflex test, the differential diagnosis of leukocoria, the ophthalmic artery chemosurgery, the trilateral retinoblastoma and the global disparity in the survival.
On this page
Study tools
Target exams
This child has the classic presentation of an intraocular retinoblastoma detected by the parent and confirmed by the red reflex test and the imaging, and the task is to outline the urgent referral pathway, the risk-adapted management and the genetic counselling, contrasting the heritable bilateral disease with the trilateral retinoblastoma and the global disparity in the survival. [1][2]
Question 1 (10 marks)
Outline the initial assessment and the urgent referral pathway for this fourteen-month-old boy with the leukocoria. [1]
A full-mark answer covers the red reflex test, the urgency of the referral, the examination under anaesthesia, the imaging and the genetic testing. [2]
The red reflex test and the urgency (2 marks). The leukocoria, the white pupillary reflex, is retinoblastoma until proven otherwise, and it demands a same-day referral to the ophthalmology service. The red reflex is performed in the dim room with the direct ophthalmoscope at thirty centimetres from the child, comparing the two eyes, and the cream-white reflex on the left is abnormal. The delay of the weeks can convert the curable intraocular tumour into the lethal extraocular disease, and the same-day referral is the non-negotiable step. [1][2]
The examination under anaesthesia (3 marks). The ophthalmology service performs the examination under anaesthesia with the indirect ophthalmoscopy, the fundus photography and the measurement of the tumour, and maps every tumour and assigns the International Intraocular Retinoblastoma Classification group. The ocular ultrasound confirms the intraocular mass with the calcification that is the hallmark of the retinoblastoma, and the contrast-enhanced magnetic resonance imaging of the orbits and the brain excludes the optic nerve invasion, the extraocular extension and the pineal mass of the trilateral retinoblastoma. The computed tomography is avoided because of the radiation and the second-malignancy risk in the heritable disease. [1][8]
The differential and the staging (3 marks). The retinoblastoma is distinguished from the congenital cataract by the retinal rather than the lens location of the opacity, from the Coats disease by the older age of the boy and the absence of the telangiectatic vessels, from the persistent fetal vasculature by the absence of the microphthalmia, and from the toxocariasis by the age and the serology. The intraocular calcification on the ultrasound confirms the retinoblastoma. The staging integrates the International Intraocular Retinoblastoma Classification group, the optic nerve and the choroidal invasion, and the absence of the metastatic disease. [1]
The genetic testing (2 marks). The RB1 gene is sequenced from the blood and, where possible, from the tumour tissue, and the identification of the germline mutation confirms the heritable form. The genetic testing is performed on every child with the retinoblastoma, including the unilateral disease, because roughly fifteen percent of the unilateral cases carry the germline mutation, and the identification changes the surveillance and the offspring counselling. [4][7]
References7ShowHide
- [1]Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers, 2015.PMID 27189421
- [2]Fabian ID, Abdallah E, Abdullahi SU, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol, 2020.PMID 32105305
- [4]Thériault BL, Dimaras H, Gallie BL, et al. The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol, 2014.PMID 24433356
- [7]Sábado Alvarez C Molecular biology of retinoblastoma. Clin Transl Oncol, 2008.PMID 18628066
- [8]Rodjan F, de Graaf P, Brisse HJ, et al. Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission. J Neurooncol, 2012.PMID 22802019
- [9]Mouratova T Trilateral retinoblastoma: a literature review, 1971-2004. Bull Soc Belge Ophtalmol, 2005.PMID 16281731
- [10]Taich P, Requejo F, Asprea M, et al. Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery. PLoS One, 2016.PMID 26959658